COPD phenotype description using principal components analysis

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Roy, Kay ^a   Smith, Jacky ^a   Kolsum, Umme ^a   Borrill, Zöe ^a   Vestbo, Jørgen ^a   Singh, Dave ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 8; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; HUMAN; INSPIRATORY CAPACITY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; SPUTUM LEVEL; BLOOD; BODY MASS; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOKING; SPUTUM;

AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69749122886     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-41     Document Type: Article

References (34)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2008, http://www.goldcopd.com
2. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006, 130(5):1541-6. 10.1378/chest.130.5.1541, 17099035.
3. Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res 2006, 7:136. 1664562, 17112387, 10.1186/1465-9921-7-136.
4. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000, 356(9240):1480-5. 10.1016/S0140-6736(00)02872-5, 11081531.
5. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995, 152(2):609-12.
6. Corradi M, Majori M, Cacciani GC, Consigli GF, de'Munari E, Pesci A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999, 54(7):572-5. 1745512, 10377199.
7. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(5):1773-7.
8. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(3 Pt 1):998-1002.
9. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59(7):574-80. 1747070, 15223864, 10.1136/thx.2003.019588.
10. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107(11):1514-9. 10.1161/01.CIR.0000056767.69054.B3, 12654609.
11. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61(10):849-53. 10.1136/thx.2006.059808, 16738034.
12. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O' Connor GT, Benjamin EJ. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008, 133(1):19-25. 10.1378/chest.07-0058, 17908709.
13. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006, 61(1):17-22. 2080712, 16055618, 10.1136/thx.2005.041996.
14. Tabachnick BG, Fidell LS. Using multivariate statistics. 2001, Boston, USA. Allyn and Bacon, 4.
15. Stevens JP. Applied multivariate statistics for the social sciences. 1992, Hillsdale, New Jersey, USA. Erlbaum, 2.
16. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Stolk J, Sont JK, Jansen DF, Kerstjens HA, Postma DS, Sterk PJ. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170(5):499-504. 10.1164/rccm.200401-112OC, 15172889.
17. Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, Effros R, Horvath I. ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006, 3(2):131-45. 10.1513/pats.200406-710ST, 16565422.
18. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154(2 Pt 1):308-17.
19. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005, 35(10):1254-62. 10.1111/j.1365-2222.2005.02344.x, 16238783.
20. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2001, 2(5):269-72. 59514, 11686894, 10.1186/rr67.
21. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173(1):79-83. 10.1164/rccm.200505-969OC, 16368793.
22. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jorres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(1):216-20.
23. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994, 7(4):725-9. 10.1183/09031936.94.07040725, 8005256.
24. Nguyen HQ, Altinger J, Carrieri-Kohlman V, Gormley JM, Stulbarg MS. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease. J Pain Symptom Manage 2003, 25(2):118-127. 10.1016/S0885-3924(02)00690-5, 12590027.
25. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 145(2):467-470.
26. Borrill Z, Clough D, Truman N, Morris J, Langley S, Singh D. A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med 2006, 100(8):1392-6. 10.1016/j.rmed.2005.11.018, 16431095.
27. Rutgers SR, Mark TW, Coers W, Moshage H, Timens W, Kauffman HF, Koeter GH, Postma DS. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 1999, 54(7):576-80. 1745531, 10377200.
28. Siva R, Green RH, Brightling CE, Shelley M, Hargadon B, McKenna S, Monteiro W, Berry M, Parker D, Wardlaw AJ, Pavord ID. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007, 29(5):906-13. 10.1183/09031936.00146306, 17301099.
29. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347(20):1557-65. 10.1056/NEJMoa021993, 12432042.
30. Stanescu D, Sanna A, Veriter C, Kostianev S, Calcagni PG, Fabbri LM, Maestrelli P. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996, 51(3):267-71. 1090637, 8779129, 10.1136/thx.51.3.267.
31. Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167(8):1090-5. 10.1164/rccm.200210-1179OC, 12684248.
32. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364(9435):709-21. 10.1016/S0140-6736(04)16900-6, 15325838.
33. Olivieri M, Corradi M, Malerba M. Gender and exhaled nitric oxide. Chest 2007, 132(4):1410. 10.1378/chest.07-0741, 17934135.
34. Sundy JS, Hauswirth DW, Mervin-Blake S, Fernandez CA, Patch KB, Alexander KM, Allgood S, McNair PD, Levesque MC. Smoking is associated with an age-related decline in exhaled nitric oxide. Eur Respir J 2007, 30(6):1074-81. 10.1183/09031936.00087807, 17928310.